nikhilsaggi1

nikhilsaggi1

Yatharth Hospitals is the 8th and 10th largest private hospital in the NCR. As of March 31, 2023, they engaged 609 doctors and offer healthcare services across several specialties and super specialties.

nikhilsaggi1

Date : 11th Feb 2024 CMP : 146.30 Potential Target : 17% The company has business presence across 75+ countries across the globe. It is largely export oriented; exports accounts for ~80% of company's revenues. In FY21, regulated markets contributed ~52% of total sales while semi-regulated markets accounted for ~41% of revenues

nikhilsaggi1

The company is working on launching new products, including steel TMT bars and electricity derivatives Increase in Net Profit Increase in Sales Increase in Operating Margin

nikhilsaggi1

Orient green Started another leg of up run CMP: 28.4

nikhilsaggi1

CMP: 291.55 Strong recent earnings growth: The company has seen an impressive profit growth of 35.49% in the last year and 51.6% over the past two years. High future earnings forecast: Analysts predict Genuspower's earnings to grow by 53.28% per year in the coming years. Stable share price: The stock has shown relatively low volatility in the past few...

nikhilsaggi1

the second largest distributor of IT products in India, it is a premier distributor of products for 200 + global technology vendors. It also leverage its presence in the field of Repairs and maintenance of technology products & Infrastructure.

nikhilsaggi1

Momentum Breakout is possible Fundamentals looks good Cup with handle in making

nikhilsaggi1

Date 28th January Strong fundamentals with growth in sales, Netprofit, Operating profits Current CMP is 3734 Potential 1st Target is 4162 Potential 2nd Target is 5000

nikhilsaggi1

10% Uptrend due to range-bound strategy In the future, it will be CWH pattern

nikhilsaggi1

ICICI Lombard General Insurance 2nd largest player in the general insurance sector. V40 Stock CMP: 1415 ATH : 1629 DII & FII has increased their percentage in this stock YOY Growth in sales / Net profit and Operating Profit Heavy Reserves & Almost Zero Borrowings

nikhilsaggi1

Zydus Lifesciences Top 5 Pharama company in India CMP : 676 PE : 21.9 Sales: Constant YOY Growth Operating Profit : Constant YOY Growth Almost no borrowing Huge reseve CWIP positive Promoter holding > 70% Increases FII in Sep 23